BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

764 related articles for article (PubMed ID: 27760321)

  • 1. A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia.
    Tzelepis K; Koike-Yusa H; De Braekeleer E; Li Y; Metzakopian E; Dovey OM; Mupo A; Grinkevich V; Li M; Mazan M; Gozdecka M; Ohnishi S; Cooper J; Patel M; McKerrell T; Chen B; Domingues AF; Gallipoli P; Teichmann S; Ponstingl H; McDermott U; Saez-Rodriguez J; Huntly BJP; Iorio F; Pina C; Vassiliou GS; Yusa K
    Cell Rep; 2016 Oct; 17(4):1193-1205. PubMed ID: 27760321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Exploration of novel therapeutic targets in acute myeloid leukemia via genome-wide CRISPR screening].
    Yamauchi T
    Rinsho Ketsueki; 2019; 60(7):810-817. PubMed ID: 31391371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface antigen-guided CRISPR screens identify regulators of myeloid leukemia differentiation.
    Wang E; Zhou H; Nadorp B; Cayanan G; Chen X; Yeaton AH; Nomikou S; Witkowski MT; Narang S; Kloetgen A; Thandapani P; Ravn-Boess N; Tsirigos A; Aifantis I
    Cell Stem Cell; 2021 Apr; 28(4):718-731.e6. PubMed ID: 33450187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unraveling therapeutic targets in acute myeloid leukemia through multiplexed genome editing CRISPR screening.
    Tian Z; Octaviani S; Huang J
    Expert Opin Ther Targets; 2023; 27(12):1173-1176. PubMed ID: 38069633
    [No Abstract]   [Full Text] [Related]  

  • 5. Loss of Kat2a enhances transcriptional noise and depletes acute myeloid leukemia stem-like cells.
    Domingues AF; Kulkarni R; Giotopoulos G; Gupta S; Vinnenberg L; Arede L; Foerner E; Khalili M; Adao RR; Johns A; Tan S; Zeka K; Huntly BJ; Prabakaran S; Pina C
    Elife; 2020 Jan; 9():. PubMed ID: 31985402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Target Discovery Using High-Throughput Genetic Screens in Acute Myeloid Leukemia.
    Liu Q; Garcia M; Wang S; Chen CW
    Cells; 2020 Aug; 9(8):. PubMed ID: 32806592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting differentiation blockade in AML: New hope from cell-surface-based CRISPR screens.
    Su R; Qing Y; Chen J
    Cell Stem Cell; 2021 Apr; 28(4):585-587. PubMed ID: 33798415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome wide CRISPR screening reveals a role for sialylation in the tumorigenesis and chemoresistance of acute myeloid leukemia cells.
    Lee DH; Kang SH; Choi DS; Ko M; Choi E; Ahn H; Min H; Oh SJ; Lee MS; Park Y; Jin HS
    Cancer Lett; 2021 Jul; 510():37-47. PubMed ID: 33872695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220.
    Hou P; Wu C; Wang Y; Qi R; Bhavanasi D; Zuo Z; Dos Santos C; Chen S; Chen Y; Zheng H; Wang H; Perl A; Guo D; Huang J
    Cancer Res; 2017 Aug; 77(16):4402-4413. PubMed ID: 28625976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Mitochondrial Structure Sensitizes Acute Myeloid Leukemia to Venetoclax Treatment.
    Chen X; Glytsou C; Zhou H; Narang S; Reyna DE; Lopez A; Sakellaropoulos T; Gong Y; Kloetgen A; Yap YS; Wang E; Gavathiotis E; Tsirigos A; Tibes R; Aifantis I
    Cancer Discov; 2019 Jul; 9(7):890-909. PubMed ID: 31048321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of CRISPR targeting for proliferation and cytarabine resistance control genes in the acute myeloid leukemia cell line MOLM-13.
    Prajapati SC; Dunham N; Fan H; Garrett-Bakelman FE
    Biotechniques; 2022 Mar; 72(3):81-84. PubMed ID: 35119307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in vivo genome-wide CRISPR screen identifies the RNA-binding protein Staufen2 as a key regulator of myeloid leukemia.
    Bajaj J; Hamilton M; Shima Y; Chambers K; Spinler K; Van Nostrand EL; Yee BA; Blue SM; Chen M; Rizzeri D; Chuah C; Oehler VG; Broome HE; Sasik R; Scott-Browne J; Rao A; Yeo GW; Reya T
    Nat Cancer; 2020 Apr; 1(4):410-422. PubMed ID: 34109316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia.
    Rau RE; Rodriguez BA; Luo M; Jeong M; Rosen A; Rogers JH; Campbell CT; Daigle SR; Deng L; Song Y; Sweet S; Chevassut T; Andreeff M; Kornblau SM; Li W; Goodell MA
    Blood; 2016 Aug; 128(7):971-81. PubMed ID: 27335278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo genome-wide CRISPR screening in murine acute myeloid leukemia uncovers microenvironmental dependencies.
    Mercier FE; Shi J; Sykes DB; Oki T; Jankovic M; Man CH; Kfoury YS; Miller E; He S; Zhu A; Vasic R; Doench J; Orthwein A; Michor F; Scadden DT
    Blood Adv; 2022 Sep; 6(17):5072-5084. PubMed ID: 35793392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic drug screen identifies the histone deacetylase inhibitor NSC3852 as a potential novel drug for the treatment of pediatric acute myeloid leukemia.
    Wiggers CRM; Govers AMAP; Lelieveld D; Egan DA; Zwaan CM; Sonneveld E; Coffer PJ; Bartels M
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27785. PubMed ID: 31044544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR screen identifies genes that sensitize AML cells to double-negative T-cell therapy.
    Soares F; Chen B; Lee JB; Ahmed M; Ly D; Tin E; Kang H; Zeng Y; Akhtar N; Minden MD; He HH; Zhang L
    Blood; 2021 Apr; 137(16):2171-2181. PubMed ID: 33270841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buffering noise: KAT2A modular contributions to stabilization of transcription and cell identity in cancer and development.
    Arede L; Pina C
    Exp Hematol; 2021 Jan; 93():25-37. PubMed ID: 33223444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia.
    Chen C; Liu Y; Rappaport AR; Kitzing T; Schultz N; Zhao Z; Shroff AS; Dickins RA; Vakoc CR; Bradner JE; Stock W; LeBeau MM; Shannon KM; Kogan S; Zuber J; Lowe SW
    Cancer Cell; 2014 May; 25(5):652-65. PubMed ID: 24794707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genome-wide aberrant RNA splicing in patients with acute myeloid leukemia identifies novel potential disease markers and therapeutic targets.
    Adamia S; Haibe-Kains B; Pilarski PM; Bar-Natan M; Pevzner S; Avet-Loiseau H; Lode L; Verselis S; Fox EA; Burke J; Galinsky I; Dagogo-Jack I; Wadleigh M; Steensma DP; Motyckova G; Deangelo DJ; Quackenbush J; Stone R; Griffin JD
    Clin Cancer Res; 2014 Mar; 20(5):1135-45. PubMed ID: 24284058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Multiplex CRISPR-Screen Identifies PLA2G4A as Prognostic Marker and Druggable Target for HOXA9 and MEIS1 Dependent AML.
    Hassan JJ; Lieske A; Dörpmund N; Klatt D; Hoffmann D; Kleppa MJ; Kustikova OS; Stahlhut M; Schwarzer A; Schambach A; Maetzig T
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502319
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 39.